More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
Rural Communities Opioid Response Program (RCORP) Evaluation
Abt supports HRSA’s rural opioid response by evaluating RCORP grants, strengthening reporting quality, and guiding targeted support for communities.
Where Data Meets Discovery: A One Health Conversation with Adam Schaefer
Abt's Adam Schaefer joins Dr. Ginger Dixon on One Health Wednesdays to explore the science, systems, and leadership driving meaningful progress in One Health research.
Potomac Officers Club AI Summit 2026
Abt delivers AI that agencies can use now, mission-ready solutions that support responsible adoption, operational fit, and measurable results.
CMS Quality Conference 2026
We combine deep expertise in policy and data with advanced analytics and business intelligence tools to help CMS programs achieve maximum performance.